SCHEMBL4516279

SCHEMBL4516279

CCc1c(OCc2ccccc2CN)ncn(Cc2ccc(OC)cc2)c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 1/20 0.40
ROCK1 Q13464 1/20 0.40
MAPK14 Q16539 1/20 0.39
LMNA P02545 3/20 0.39
TSHR P16473 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
KDM4E B2RXH2 1/20 0.39
CYP11B2 P19099 2/20 0.39
HPGD P15428 1/20 0.39
NPBWR1 P48145 1/20 0.39
MAPT P10636 3/20 0.38
TP53 P04637 2/20 0.38
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38
MMP13 P45452 1/20 0.38
CYP11B1 P15538 1/20 0.38
GABRA5 P31644 1/20 0.37
CSF1R P07333 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4524327 0.91 MAPK14 (0.48) MAPK14LMNAKMT2AKDM4EHPGD
SCHEMBL4510187 0.85 NPBWR1 (0.48) MAPK14KMT2AKDM4ENPBWR1MAPT
SCHEMBL3521590 0.78 MAPK14 (0.62) MAPK14LMNAMEN1KMT2AKDM4E
SCHEMBL4514301 0.75 MAPK14 (0.46) MAPK14KMT2AKDM4EHPGDNPBWR1
SCHEMBL4522650 0.69 MAPK14 (0.49) MAPK14L3MBTL1KDM4EMAPT
SCHEMBL3527773 0.68 HPGD (0.54) ROCK2ROCK1LMNATSHRMEN1
SCHEMBL4512362 0.68 KDM4E (0.44) MAPK14MEN1KMT2AL3MBTL1KDM4E
SCHEMBL4499526 0.68 MAPK14 (0.48) MAPK14KDM4EMAPT
SCHEMBL3520639 0.68 MAPK14 (0.48) ROCK2ROCK1MAPK14LMNATSHR
SCHEMBL4511812 0.67 MAPK14 (0.62) MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270350-A1 Pyridinone Pyrazole Urea and Pyrimidinone Pyrazole Urea Derivatives PFIZER INC. 2009-10-29 US disclosed
US-20090270350-A1 Pyridinone Pyrazole Urea and Pyrimidinone Pyrazole Urea Derivatives PFIZER INC. 2009-10-29 US disclosed
US-20090270350-A1 Pyridinone Pyrazole Urea and Pyrimidinone Pyrazole Urea Derivatives PFIZER INC. 2009-10-29 US disclosed
EP-1987022-A1 PYRIDINONE PYRAZOLE UREA AND PYRIMIDINONE PYRAZOLE UREA DERIVATIVES Pfizer Products Inc. (US) 2008-11-05 EP disclosed
WO-2007091176-A1 PYRIDINONE PYRAZOLE UREA AND PYRIMIDINONE PYRAZOLE UREA DERIVATIVES PFIZER PRODUCTS INC. (US) 2007-08-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270350-A1 Pyridinone Pyrazole Urea and Pyrimidinone Pyrazole Urea Derivatives PDXK, UMPS, CDK2 ROCK2 276/4885ROCK1 463/4885MAPK14 117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.